Q11981 (Q11981): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claims)
(‎Changed an Item)
Property / EU contribution
 
225,000.0 Czech koruna
Amount225,000.0 Czech koruna
UnitCzech koruna
Property / EU contribution: 225,000.0 Czech koruna / rank
 
Normal rank
Property / EU contribution
 
9,000.0 Euro
Amount9,000.0 Euro
UnitEuro
Property / EU contribution: 9,000.0 Euro / rank
 
Preferred rank
Property / EU contribution: 9,000.0 Euro / qualifier
 
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
Property / EU contribution: 9,000.0 Euro / qualifier
 
point in time: 10 January 2020
Timestamp+2020-01-10T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / budget
 
300,000.0 Czech koruna
Amount300,000.0 Czech koruna
UnitCzech koruna
Property / budget: 300,000.0 Czech koruna / rank
 
Normal rank
Property / budget
 
12,000.0 Euro
Amount12,000.0 Euro
UnitEuro
Property / budget: 12,000.0 Euro / rank
 
Preferred rank
Property / budget: 12,000.0 Euro / qualifier
 
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
Property / budget: 12,000.0 Euro / qualifier
 
point in time: 10 January 2020
Timestamp+2020-01-10T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 02:31, 12 February 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
No label defined
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    225,000.0 Czech koruna
    0 references
    9,000.0 Euro
    10 January 2020
    0 references
    300,000.0 Czech koruna
    0 references
    12,000.0 Euro
    10 January 2020
    0 references
    75 percent
    0 references
    4 September 2019
    0 references
    30 November 2018
    0 references
    mcePharma s. r. o.
    0 references
    0 references

    49°46'2.53"N, 18°0'27.29"E
    0 references
    74301
    0 references
    Projekt vývoj technologie a produktu - doplňku stravy pro účel prevence a mírnění deprese, bude založen na bázi účinných rostlinných extraktů, a to v inovativní uživatelské podobě jako např. ve formě sticků, tablet a minitablet a na základě výsledků vývoje poskytnutých partnerskou vědecko-výzkumnou institucí. Uvedením na trh opravdu účinného doplňku stravy získá společnost ojedinělé postavení na trhu a bude moci dále rozvíjet spolupráci s výzkumnými organizacemi. a. (Czech)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_115/0012660
    0 references